23 May 2017 - Cancer care is expensive, and like other chronic illnesses, is prone to waste both through overuse of low-value services and underuse of evidence-based approaches.

The fee-for-service model has been cited as a major factor, creating perverse incentives to provide high-cost, low-value care without sufficiently monitoring quality.

Alternative models have been proposed as a means to both control costs and improve quality in oncology, including accountable care organisations, bundled episode-based payment models, and patient-centred medical homes.

Read JAMA article